Revised Moderna Vaccine Works Better Against Omicron, Trial Suggests
Moderna released results on Wednesday on an updated coronavirus vaccine targeting the Omicron variant, calling it “our lead candidate” to serve as a booster shot in the fall. The firm’s researchers tested a booster dose combining the original vaccine with one targeted specifically against Omicron, the variant that became dominant last winter. They found that…